Invitrogen Corporation
5791 Van Allen Way
P.O. Box 6482
Carlsbad
California
92008
U.S.A.
Phone:
760-603-7200
Fax:
760-602-6500
|
|
Invitrogen Corporation (Nasdaq:IVGN) provides products and services that support academic and government research institutions as well as pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery, including functional genomics, proteomics, bioinformatics and cell biology - placing Invitrogen's products in nearly every major laboratory in the world.
Founded in 1987, Invitrogen is celebrating 20 years of accelerating scientific discovery. The company is headquartered in Carlsbad, California, and conducts business in more than 70 countries around the world. Invitrogen globally employs approximately 4,300 scientists and other professionals and had revenues of more than $1.3 billion in 2007. Invitrogen has eight manufacturing locations in North America, Europe and Asia, operations in more than 20 countries, and distributor relationships in 70 countries worldwide.
Corporate Management:
Gregory T. Lucier - Chairman and CEO
David F. Hoffmeister - Senior Vice President, Chief Financial Officer
Claude D. Benchimol, Ph.D.- Senior Vice President, Advanced Systems R & D
John A. Cottingham - Senior Vice President, General Counsel and Corporate Secretary
Peter Leddy, Ph. D.- Senior Vice President, Human Resources
Paul Grossman, Ph.D. - Senior Vice President, Strategy and Corporate Development
Nicolas M. Barthelemy - Senior Vice President, Cell Culture Systems
Kip Miller - Senior Vice President, BioDiscovery
Amanda Clardy - Vice President, Investor Relations
Kelli Richard - Vice President, Finance & Chief Accounting Officer
Bernd Brust - Senior Vice President, Global Sales and Marketing
Business Units:
Functional Genomics, Drug Discovery Solutions, Detection Technologies, BioProduction, Cell Culture, Biological Defense Systems
Email:
Ownership:
Web Site:
Invitrogen Corporation
Employees:
Over 4,300 worldwide
Symbol: IVGN
|